Healthcare

In the U.S., some hospitals require cognitive assessments for clinicians above a certain age to renew their privileges. The figures are intriguing, but the model raises questions of validity and fairness. In Quebec, the Collège des médecins du Québec is relying on other mechanisms.

The National Advisory Committee on Immunization recommends adding clesrovimab to the arsenal of preventive measures against respiratory syncytial virus in infants and young children. This monoclonal antibody was approved by Health Canada in February 2026.